Health and medicine/Medical specialties/Oncology/Tumor regression
A experimental human papilloma virus (HPV) vaccine may be capable of killing cervical cancer cells, according to an early clinical study of the vaccine published in the 10 October issue of the journal Science Translational Medicine.